Cryptocurrencies
Eli Lilly slumps after slashing profit outlook despite weight-loss drug earnings boost
Eli Lilly LLY posted better-than-expected third quarter earnings Thursday thanks to the ongoing surge in sales for its Mounjaro anti-obesity drug that offset a slump in revenues for its legacy diabetes treatment Trulicity. Shares in the group Read more…